Medical Citation URL Suran M
Higher doses of certain GLP-1 medications have subsequently received FDA approval specifically for chronic weight management in adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Skibicka, K
The anti-AS effect of the optimized SSPH-MPN was evaluated by monitoring oxidative status (ROS levels, antioxidant enzymes SOD, GSH-Px, MDA, T-AOC), inflammatory markers (IL-1, IL-6, TNF-), lipid metabolism (DiI-oxLDL uptake, cholesterol efflux, blood lipid levels, lipid accumulation), and plaque areas
Kahn says, but clinical studies show tirzepatide (Zepbound) typically produces more substantial results when it comes to weight loss
Cruz F, Scott SR, Barroso I, et al